Atiprimod dimaleate is an antiproliferative and antiangiogenic agent that inhibits the proliferation of cancer cell lines; induces apoptosis by activating caspase-9 and caspase-3 in T84 colon cancer cells; inhibits bFGF- and VEGF-induced proliferation and migration of human umbilical vein endothelial cells, thereby disrupting tube formation; and reduces the production of IL-6 and VEGF while suppressing Stat3 activation.